SAB-142

· SAb Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAB-142, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes [Phase 2]

See pricing